ATE424857T1 - Übertragung von anti-infektiöser aktivität auf wundverbände - Google Patents
Übertragung von anti-infektiöser aktivität auf wundverbändeInfo
- Publication number
- ATE424857T1 ATE424857T1 AT00972353T AT00972353T ATE424857T1 AT E424857 T1 ATE424857 T1 AT E424857T1 AT 00972353 T AT00972353 T AT 00972353T AT 00972353 T AT00972353 T AT 00972353T AT E424857 T1 ATE424857 T1 AT E424857T1
- Authority
- AT
- Austria
- Prior art keywords
- iodine
- infective
- wound
- dressing
- wound site
- Prior art date
Links
- 230000002924 anti-infective effect Effects 0.000 title abstract 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 7
- 229910052740 iodine Inorganic materials 0.000 abstract 7
- 239000011630 iodine Substances 0.000 abstract 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical compound I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 abstract 2
- 102000016938 Catalase Human genes 0.000 abstract 1
- 108010053835 Catalase Proteins 0.000 abstract 1
- 102000008015 Hemeproteins Human genes 0.000 abstract 1
- 108010089792 Hemeproteins Proteins 0.000 abstract 1
- 229960005475 antiinfective agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003641 microbiacidal effect Effects 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16052199P | 1999-10-20 | 1999-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424857T1 true ATE424857T1 (de) | 2009-03-15 |
Family
ID=22577228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00972353T ATE424857T1 (de) | 1999-10-20 | 2000-10-20 | Übertragung von anti-infektiöser aktivität auf wundverbände |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6592890B1 (de) |
| EP (1) | EP1221985B1 (de) |
| JP (1) | JP2003512095A (de) |
| AT (1) | ATE424857T1 (de) |
| AU (1) | AU1102801A (de) |
| DE (1) | DE60041775D1 (de) |
| WO (1) | WO2001028600A1 (de) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4699799A (en) | 1998-06-19 | 2000-01-05 | Oxibio, Inc. | Medical device having anti-infective and contraceptive properties |
| US6838050B1 (en) | 1999-06-04 | 2005-01-04 | Oxibio, Inc. | Methods and devices for providing anti-infective activity to a medical device |
| US6890850B2 (en) | 2001-12-14 | 2005-05-10 | Applied Materials, Inc. | Method of depositing dielectric materials in damascene applications |
| US7091137B2 (en) * | 2001-12-14 | 2006-08-15 | Applied Materials | Bi-layer approach for a hermetic low dielectric constant layer for barrier applications |
| US6838393B2 (en) * | 2001-12-14 | 2005-01-04 | Applied Materials, Inc. | Method for producing semiconductor including forming a layer containing at least silicon carbide and forming a second layer containing at least silicon oxygen carbide |
| US20030133893A1 (en) * | 2002-01-15 | 2003-07-17 | Degania Silicone Ltd. | Compositions and methods for treating skin ailments |
| EP1358893A1 (de) * | 2002-04-24 | 2003-11-05 | Insense Limited | Verband enthaltend eine Oxidoreduktase und eine Peroxidase |
| PT1693073E (pt) * | 2002-04-24 | 2014-09-18 | Archimed Llp | Pensos para feridas incluindo hidrogéis hidratados e enzimas |
| EP1551356A2 (de) * | 2002-09-03 | 2005-07-13 | Biovail Laboratories Incorporated | Pravastatin zubereitungen und deren verwendung |
| US7749563B2 (en) * | 2002-10-07 | 2010-07-06 | Applied Materials, Inc. | Two-layer film for next generation damascene barrier application with good oxidation resistance |
| EP1587551A2 (de) * | 2003-01-24 | 2005-10-26 | Rose-Hulman Institute of Technology | Durch licht nicht aktivierbarer klebstoffverbund und verfahren |
| US7501133B2 (en) | 2003-01-24 | 2009-03-10 | Rose-Hulman Institute Of Technology | Light-activated adhesive composite, system, and methods of use thereof |
| GB0313217D0 (en) | 2003-06-09 | 2003-07-16 | Insense Ltd | Improvements in or relating to skin dressings |
| US20050214376A1 (en) * | 2003-10-21 | 2005-09-29 | Marie-Pierre Faure | Hydrogel-containing medical articles and methods of using and making the same |
| EP1725272A1 (de) * | 2004-01-30 | 2006-11-29 | Insense Limited | Wundauflagen mit hydratisierten hydrogelen und enzymen |
| GB0427444D0 (en) * | 2004-01-30 | 2005-01-19 | Insense Ltd | Improvements relating to skin dressings |
| US7030041B2 (en) | 2004-03-15 | 2006-04-18 | Applied Materials Inc. | Adhesion improvement for low k dielectrics |
| US7229911B2 (en) | 2004-04-19 | 2007-06-12 | Applied Materials, Inc. | Adhesion improvement for low k dielectrics to conductive materials |
| JP2008503592A (ja) * | 2004-06-22 | 2008-02-07 | グレイストーン メディカル グループ、インコーポレイテッド | 徐放性組成物を用いた創傷の治療方法 |
| US7229041B2 (en) * | 2004-06-30 | 2007-06-12 | Ohio Central Steel Company | Lifting lid crusher |
| US7288205B2 (en) | 2004-07-09 | 2007-10-30 | Applied Materials, Inc. | Hermetic low dielectric constant layer for barrier applications |
| WO2006038803A2 (en) * | 2004-10-07 | 2006-04-13 | Ngen Pharmaceuticals N.V. | Composition for treating wounds and burns |
| US20080274206A1 (en) * | 2004-10-07 | 2008-11-06 | Ngen Pharmaceuticals N.V. | Stabilised Oxygen Releasing Composition |
| CA2611796C (en) * | 2005-06-13 | 2014-11-25 | Flen Pharma N.V. | Improved antimicrobial peroxidase compositions |
| GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| US8795730B2 (en) * | 2006-01-31 | 2014-08-05 | David John Vachon | Compositions and methods for promoting the healing of tissue of multicellular organisms |
| WO2007089902A2 (en) * | 2006-01-31 | 2007-08-09 | David Vachon | Compositions and methods for promoting the healing of tissue of multicellular organisms |
| US7659344B2 (en) * | 2006-06-08 | 2010-02-09 | E. I. Du Pont De Nemours And Company | Shaped articles containing poly(vinylpyrrolidone)-iodine complex |
| GB0614278D0 (en) * | 2006-07-19 | 2006-08-30 | Insense Ltd | Hydrogen peroxide delivery system |
| PL1923077T3 (pl) * | 2006-11-07 | 2011-06-30 | Hartmann Paul Ag | Wielowarstwowy, chłonny opatrunek na rany z hydrofilową warstwą stykającą się z raną |
| GB0705557D0 (en) * | 2007-03-23 | 2007-05-02 | Stead Richard G | A treatment |
| AU2013203151B2 (en) * | 2007-04-09 | 2015-05-21 | Wake Forest University Health Sciences | Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| US10493040B2 (en) * | 2007-04-09 | 2019-12-03 | Wake Forest University Health Sciences | Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| PT2243472T (pt) * | 2009-04-22 | 2017-08-04 | Medskin Solutions Dr Suwelack Ag | Composição de substâncias ativas liofilizada |
| JP5724108B2 (ja) * | 2009-04-22 | 2015-05-27 | メドスキン ソリューションズ ドクター ズベラック アーゲーMedSkin Solutions Dr.Suwelack AG | 凍結乾燥組成物 |
| AU2010282717A1 (en) * | 2009-08-10 | 2012-02-16 | Gawi Healthcare, Llc | Cooling products and methods |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| BR112014004287A2 (pt) * | 2011-08-24 | 2017-03-28 | Calgon Carbon Corp | curativo para ferimento, método para preparar um curativo para ferimento e método para tratar um ferimento |
| GB201207617D0 (en) * | 2012-05-02 | 2012-06-13 | Systagenix Wound Man Ip Co Bv | Wound dressings |
| US20130345655A1 (en) * | 2012-06-21 | 2013-12-26 | Toyota Motor Corporation | Enzyme-polymer matrix beads for de-odor applications |
| WO2014096843A2 (en) | 2012-12-20 | 2014-06-26 | Convatec Technologies Inc. | Processing of chemically modified cellulosic fibres |
| GB201308770D0 (en) | 2013-05-15 | 2013-06-26 | Convatec Technologies Inc | Wound Dressing Comprising an Antimicrobial Composition |
| WO2015080984A1 (en) | 2013-11-27 | 2015-06-04 | BioPharmX, Inc. | Solid oral dosage form for breast symptoms |
| WO2015112807A1 (en) * | 2014-01-24 | 2015-07-30 | Avent, Inc. | Traumatic wound dressing system with wrap |
| CA2947390C (en) * | 2014-04-30 | 2022-10-18 | Matoke Holdings Limited | Antimicrobial compositions |
| US20160174986A1 (en) * | 2014-07-02 | 2016-06-23 | The Cleveland Clinic Foundation | Anastomosis devices and methods of using same |
| WO2016179575A1 (en) * | 2015-05-07 | 2016-11-10 | Kci Liensing, Inc. | A controlled release iodine structure for use with wound care |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| CN107823691A (zh) * | 2017-11-06 | 2018-03-23 | 河南汇博医疗股份有限公司 | 一种含氧敷料及其制备方法 |
| WO2024135535A1 (ja) * | 2022-12-21 | 2024-06-27 | 東亞合成株式会社 | ハイドロゲル形成材 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB382572A (en) | 1931-05-16 | 1932-10-27 | Iodine Educational Bureau Inc | Improvements in or relating to surgical material |
| US4578265A (en) * | 1981-08-13 | 1986-03-25 | Laclede Professional Products, Inc. | Di-enzymatic dentifrice |
| US4783448A (en) | 1983-06-07 | 1988-11-08 | Perstorp Ab | Method for cleansing an infected sore |
| BR8407197A (pt) | 1983-11-29 | 1985-11-05 | Avtex Fibers Inc | Fibra germicida,tecido germicida,artigo de fabricacao germicidamente efidaz,objeto moldado,artigo de fabricacao,mascara cirurgica filtro de ar,tampao,fralda,almofada para cosmetico,esponja cirurgica,bandagem ou curativo e processo de formacao de iodofor com polimero formador de iodofor |
| US4576817A (en) | 1984-06-07 | 1986-03-18 | Laclede Professional Products, Inc. | Enzymatic bandages and pads |
| SE8702831L (sv) | 1987-07-10 | 1989-01-11 | Ewos Ab | Microbicid komposition |
| US5232914A (en) | 1988-04-11 | 1993-08-03 | Epitope, Inc. | Solid, storage-stable, germicidal, pre-iodine composition |
| EP0391741B1 (de) * | 1989-04-06 | 1995-04-19 | Merocel Corporation | Antimikrobielle Kunststoffmaterialien mit Breitbandwirkung |
| GB9002422D0 (en) | 1990-02-03 | 1990-04-04 | Boots Co Plc | Anti-microbial compositions |
| US5128136A (en) | 1990-07-16 | 1992-07-07 | The Oregon Health Sciences University | Wound healing kit comprised of gelable collagen |
| US5196190A (en) * | 1990-10-03 | 1993-03-23 | Zenith Technology Corporation, Limited | Synthetic skin substitutes |
| US5756090A (en) | 1991-02-21 | 1998-05-26 | Eoe, Inc. | Oxygen activatable formulations for disinfection or sterilization |
| US5888505A (en) | 1991-02-21 | 1999-03-30 | Eoe, Inc. | Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system |
| US5447505A (en) * | 1993-08-04 | 1995-09-05 | Merocel Corporation | Wound treatment method |
| TW482651B (en) | 1994-12-28 | 2002-04-11 | Baxter Int | Antimicrobial materials. |
| AU722246B2 (en) | 1995-06-07 | 2000-07-27 | Johnson & Johnson Consumer Products, Inc. | Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same |
| AU2693397A (en) * | 1996-05-09 | 1997-12-05 | Novo Nordisk A/S | Antimicrobial peroxidase compositions |
| US5744150A (en) | 1997-01-29 | 1998-04-28 | Xomed Surgical Products, Inc. | Softened antimicrobial sponge material with color change indication of antimicrobial activity |
| US6001345A (en) | 1997-11-03 | 1999-12-14 | Medlogic Global Corporation | Application of cyanoacrylate/anti-microbial compositions to the peri-wound or peri-mucosal area |
| AU4699799A (en) | 1998-06-19 | 2000-01-05 | Oxibio, Inc. | Medical device having anti-infective and contraceptive properties |
| GB9905663D0 (en) | 1999-03-12 | 1999-05-05 | Bristol Myers Squibb Co | Iodine preparation composition |
-
2000
- 2000-10-19 US US09/694,104 patent/US6592890B1/en not_active Expired - Fee Related
- 2000-10-20 EP EP00972353A patent/EP1221985B1/de not_active Expired - Lifetime
- 2000-10-20 AU AU11028/01A patent/AU1102801A/en not_active Abandoned
- 2000-10-20 JP JP2001531428A patent/JP2003512095A/ja active Pending
- 2000-10-20 WO PCT/US2000/029307 patent/WO2001028600A1/en not_active Ceased
- 2000-10-20 AT AT00972353T patent/ATE424857T1/de not_active IP Right Cessation
- 2000-10-20 DE DE60041775T patent/DE60041775D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60041775D1 (de) | 2009-04-23 |
| EP1221985A1 (de) | 2002-07-17 |
| EP1221985B1 (de) | 2009-03-11 |
| JP2003512095A (ja) | 2003-04-02 |
| US6592890B1 (en) | 2003-07-15 |
| AU1102801A (en) | 2001-04-30 |
| WO2001028600A1 (en) | 2001-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE424857T1 (de) | Übertragung von anti-infektiöser aktivität auf wundverbände | |
| DE59903367D1 (de) | Perameisensäure und Peressigsäure enthaltendes wässriges Desinfektionsmittel, Verfahren zu dessen Herstellung und dessen Verwendung | |
| AU4945085A (en) | Decontaminating subterranean formation by oxidation | |
| FI840427A0 (fi) | Foerfarande foer framstaellning av ett katalytiskt verksamt elektrodmaterial foer syrefoertaer-elektroder | |
| ATE327779T1 (de) | Methode und zusammensetzungen für verbesserte abgabevorrichtungen | |
| MXPA03009905A (es) | EMPLEO DE COMPUESTOS DE COMPLEJOS METALICOS COMO CATALIZADORES DE OXIDACIoN. | |
| WO2002086134A3 (de) | Pufferlössung für die elektroporation und verfahren umfassend die verwendung derselben | |
| WO2006016990A3 (en) | Stabilized thickened hydrogen peroxide containing compositions | |
| WO1991008981A3 (en) | Solutions for stabilizing hydrogen peroxide containing solutions | |
| ATE300602T1 (de) | Verwendung von percarbaminsäure und diacylpercarbamaten und deren vorstufen | |
| FR2825273B1 (fr) | Composition pour le traitement des signes cutanes du vieillissement | |
| DE60210085D1 (de) | Stabilitätsverstärktes persäurebleichungssystem geeignet für gewebebehandlung | |
| ES417100A1 (es) | Procedimiento de depuracion de aguas residuales sulfuradas. | |
| ES2075540T3 (es) | Procedimiento para la depilacion de pieles de animales. | |
| ATE281147T1 (de) | Haarbehandlungsverfahren | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| ATE336221T1 (de) | Dentalzusammensetzungen für überempfindliche zähne | |
| ES8500746A1 (es) | Metodo de producir una preparacion yodofora farmaceutica | |
| DE60015867D1 (de) | Wässrige Lösung aus Peressigsäure und Wasserstoffperoxid für die Desinfektion von Endoskopen | |
| DE50108958D1 (de) | Platinmetallhaltige cermetelektroden für die elektrochemische reduktion von sauerstoff | |
| DE69730023D1 (de) | Iontophoretische struktur | |
| ES8704738A1 (es) | Procedimiento para estabilizar y-0 aumentar el efecto microbicida de soluciones acuosas de h2o2 | |
| DE60141531D1 (de) | Verwendung einer wässrigen Glyzerol Lösung zur Beibehaltung der Leistungen von teildurchlässigen feuchten Membranen für die Behandlung von Blut und Plasma | |
| JP2019006744A (ja) | 殺菌水及び殺菌水の製造方法 | |
| MD1295F1 (en) | Process for obtaining an antiseptic preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |